Mumbai, Aug. 12 -- Lupin today announced that it has partnered with Sandoz Group AG (Sandoz), Switzerland, to market and commercialize Lupin's biosimilar ranibizumab across multiple regions.

Published by HT Digital Content Services with permission from Capital Market....